Nutritional Outlook Vol. 22 No. 6

While plant proteins have been trending, dairy proteins and isolates remain competitive within the protein bar space, specifically within sports nutrition.

In a market segment as old and enduring as grains, one might wonder if further innovation is possible.

Amarin Pharma’s recent comments advising FDA not to allow synthetic omega-3 supplements to be dietary supplements is just one more case in which synthetic supplement ingredients are under fire.

Researchers are finding that dietary supplementation can go a long way toward shoring up ocular health and protecting eyes against the battery of threats they face.

ChromaDex CEO Rob Fried: “Although it is uncommon, perhaps, for a company CEO to request stronger regulations and regulatory enforcement for his or her industry, that is precisely what I am doing.”

A brief look at three of the lesser-known health benefits of natural astaxanthin.

MCTs are increasingly popular among consumers and product makers, in part due to their ease of use as well as their health benefits.

CBD may be the hottest ingredient on the block, but don’t overlook hemp’s other promising cannabinoids, including cannabigerol (CBG), cannabichromene (CBC), and cannabinol (CBN). This article discusses exciting avenues of product development for manufacturers looking to work with a wider range of cannabinoids, as well as the challenges that remain.

One CEO writes about how blockchain technology is the key to addressing the complexity of today’s global dietary supplement supply chain.